Bayesian Capital Management, LP - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 209 filers reported holding SAGE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$266,000
+3.9%
6,800
+272.2%
0.05%
+12.5%
Q3 2019$256,000
+16.9%
1,827
-20.2%
0.05%
+6.7%
Q4 2018$219,000
-21.8%
2,290
-49.0%
0.04%
-32.8%
Q3 2017$280,0004,4920.07%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders